Uvisa Health ApS: Financial statements 2022
CVR: 42444383
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Uvisa Health ApS (CVR 42444383) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 72,906 and a net result of DKK 61,602. Equity in the 2022 report amounted to DKK 314,447. The solvency ratio was 91%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 72,906
- Profit/Loss
- DKK 61,602
- Equity
- DKK 314,447
- Total Assets
- DKK 345,502
- Employees
- 2
Official annual report
Keep an eye on Uvisa Health ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Uvisa Health ApS has published its interim report for the period June 7, 2021 to December 31, 2021.
About Uvisa Health ApS
Uvisa Health ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ella Jade Smoraczewska Harris. The board consists of Jesper Ahlmann Funding Andersen (chair), Malene Schrøder, Ella Jade Smoraczewska Harris and Erica Perrier. The company's owners include BORRING HOLDING A/S, Majoha ApS and Harris Holdings ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -3,331,233 and a net result of DKK -5,624,368 compared with DKK -3,028,785 the year before. Equity in the 2025 report amounted to DKK -5,067,530.